找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Information Technologies in Medicine; 5th International Co Ewa Piętka,Pawel Badura,Wojciech Wieclawek Conference proceedings 2016 Springer

[复制链接]
楼主: Clientele
发表于 2025-3-26 22:37:19 | 显示全部楼层
发表于 2025-3-27 04:43:30 | 显示全部楼层
发表于 2025-3-27 06:54:12 | 显示全部楼层
Prediction of Newborn Weight Using Questionnaire Data and Machine Learning Approach infancy and childhood. Low birth weight is a multifaceted public health problem. The prevalence of this diagnosis is estimated to be 15–20 % worldwide (more than 20 million infants) and occurs mostly in developing countries (95.6 %). There are many factors, which affect the birth weight of newborns
发表于 2025-3-27 12:41:12 | 显示全部楼层
发表于 2025-3-27 13:35:44 | 显示全部楼层
Machine Learning Can Reliably Distinguish Histological Patterns of Micropapillary and Solid Lung Adeal quantification of lung tumor composition is very time consuming, but it can potentially be aided by a machine learning application. We have updated our previously developed methodology to segment and distinguish solid and micropapillary lung tumor subtypes. Binary tumor masks delineated by machin
发表于 2025-3-27 18:28:03 | 显示全部楼层
发表于 2025-3-27 23:26:40 | 显示全部楼层
发表于 2025-3-28 02:58:29 | 显示全部楼层
Georg Aumayructs have been approved over the past several years including Rituxan, Remicade, Avastin, Humira, and Herceptin. In addition, over 300 new drugs are currently in clinical trials. With both large, established biotechnology companies and small start-ups involved in the development of this important cl
发表于 2025-3-28 08:36:13 | 显示全部楼层
发表于 2025-3-28 14:01:33 | 显示全部楼层
Kimiaki Shirahama,Marcin Grzegorzekntibodies products will become increasingly prevalent over t.Monoclonal antibodies represent one of the fastest growing areas of new drug development within the pharmaceutical industry. Several blockbuster products have been approved over the past several years including Rituxan, Remicade, Avastin,
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-23 16:47
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表